APN News

  • Tuesday, April, 2019| Today's Market | Current Time: 12:10:26
  • univadis and The Lancet Announce New Partnership

    United States : MSD (known as Merck in the United States and Canada) is pleased to announce an exciting and exclusive new partnership between univadis® – (MSD’s medical education and unbiased health information website) and The Lancet – (one of the world’s leading independent general medical journals). Through a unique global medical literature service called Just […]

    BGS Global Hospitals Offers Treatment for Stroke without Surgery

    Treatment for stroke without surgery is now possible at BGS Global Hospitals, one of the leading tertiary care multi super speciality hospitals in Bangalore, India. Advanced Neurosciences Institute at BGS Global Hospitals has added another advanced service and innovative procedure to its facilities in the treatment of stroke. The hospital will soon be equipped with […]

    IBA Introduces Proteus ONE, a Smaller, More Cost-Effective Proton Therapy System

    United States :A smaller, more efficient and cost-effective Proton Therapy system from IBA Particle Therapy will soon be available for cancer treatment centers. This single-room system is roughly one-third the size of the current gantry configuration and offers a smaller cyclotron, a shorter proton-beam route from the cyclotron to the treatment room, and a more […]

    Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Shows Rapid Viral Response without Use of Pegylated Interferon

    United States : Boehringer Ingelheim announced results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127, with ribavirin reduced viral load to the lower limit of quantifiable levels in HCV treatment-naïve patients. The regimen did […]

    Scientists uncover cancer’s hiding spots

    In a discovery that could lead to new treatments to prevent relapse of cancer, scientists have claimed to have uncovered how a small number of cancer cells escape from chemotherapy by hiding in a protective shield. In a study of mice, biologists at the Massachusetts Institute of Technology (MIT) in Cambridge found that a few […]

    Blood test to spot ectopic pregnancy

    In what’s being claimed as a key breakthrough which could save fertility of thousands of women, scientists have developed a simple blood test that can detect ectopic pregnancy within a day. Ectopic pregnancies occur when the foetus implants itself outside of the womb, usually in one of the fallopian tubes. The baby can never be […]

    St. Jude Medical to Showcase Portfolio of Products at Asia-Pacific Heart Rhythm 2010

    United States :St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced it will display a number of ground breaking technologies and clinical solutions from the company’s Cardiac Rhythm Management and Atrial Fibrillation Divisions at the 3rd annual Asia-Pacific Heart Rhythm Society Scientific Session (APHRS), which is held in conjunction with the 6th annual […]

    New Therapeutic Surface from KCI Enhances Skin Integrity for the Prevention and Management of Pressure Ulcers

    United States: Kinetic Concepts, Inc. (NYSE: KCI) announced the U.S. launch of Skin IQ™ Microclimate Manager (Skin IQ™ MCM) through KCI’s Therapeutic Support Systems business. Skin IQ™ MCM is a for-sale, powered coverlet offering clinicians one of the most effective and intuitive products available for the prevention and management of pressure ulcers. An estimated 10-18 […]

    Octapharma Clinical Trial Begins in the US and Germany

    Lachen: Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with […]

    PRADAX™ (dabigatran etexilate) gains approval in Canada for stroke prevention in atrial fibrillation

    Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate),1 Boehringer Ingelheim’s novel, oral direct thrombin inhibitor2 for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food […]